PortfoliosLab logoPortfoliosLab logo
OLMA vs. ACLX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

OLMA vs. ACLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Olema Pharmaceuticals, Inc. (OLMA) and Arcellx Inc (ACLX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


OLMA

1D
-1.68%
1M
-28.16%
YTD
-57.96%
6M
-61.43%
1Y
159.51%
3Y*
22.84%
5Y*
-17.63%
10Y*

ACLX

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

OLMA vs. ACLX - Yearly Performance Comparison


2026 (YTD)2025202420232022
OLMA
Olema Pharmaceuticals, Inc.
-57.96%328.82%-58.45%472.65%-58.33%
ACLX
Arcellx Inc
76.49%-14.98%38.18%79.15%84.40%

Correlation

The correlation between OLMA and ACLX is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.25

Correlation (3Y)
Calculated over the trailing 3-year period

0.27

Correlation (All Time)
Calculated using the full available price history since Feb 7, 2022

0.23

Fundamentals

EPS

OLMA:

-$2.03

ACLX:

-$3.86

Total Revenue (TTM)

OLMA:

$0.00

ACLX:

$35.90M

Gross Profit (TTM)

OLMA:

-$187.00K

ACLX:

$810.00K

EBITDA (TTM)

OLMA:

-$197.79M

ACLX:

-$209.52M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Olema Pharmaceuticals, Inc.

Arcellx Inc

Return for Risk

OLMA vs. ACLX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OLMA
OLMA Risk / Return Rank: 8080
Overall Rank
OLMA Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
OLMA Sortino Ratio Rank: 9191
Sortino Ratio Rank
OLMA Omega Ratio Rank: 8989
Omega Ratio Rank
OLMA Calmar Ratio Rank: 7777
Calmar Ratio Rank
OLMA Martin Ratio Rank: 7474
Martin Ratio Rank

ACLX
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OLMA vs. ACLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Olema Pharmaceuticals, Inc. (OLMA) and Arcellx Inc (ACLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


OLMAACLXDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.43

Calmar ratioReturn relative to maximum drawdown

2.27

Martin ratioReturn relative to average drawdown

4.83

OLMA vs. ACLX - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


OLMAACLXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.00

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.16

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.23

Drawdowns

OLMA vs. ACLX - Drawdown Comparison


Loading charts...

Drawdown Indicators


OLMAACLXDifference

Max Drawdown

Largest peak-to-trough decline

-96.26%

Max Drawdown (1Y)

Largest decline over 1 year

-70.67%

Max Drawdown (3Y)

Largest decline over 3 years

-82.15%

Max Drawdown (5Y)

Largest decline over 5 years

-93.36%

Current Drawdown

Current decline from peak

-80.72%

Average Drawdown

Average peak-to-trough decline

-74.98%

Ulcer Index

Depth and duration of drawdowns from previous peaks

33.14%

Volatility

OLMA vs. ACLX - Volatility Comparison


Loading charts...

Volatility by Period


OLMAACLXDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.66%

Volatility (6M)

Calculated over the trailing 6-month period

55.93%

Volatility (1Y)

Calculated over the trailing 1-year period

160.52%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

107.97%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

106.41%

Dividends

OLMA vs. ACLX - Dividend Comparison

Neither OLMA nor ACLX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

OLMA vs. ACLX - Financials Comparison

This section allows you to compare key financial metrics between Olema Pharmaceuticals, Inc. and Arcellx Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00M50.00M60.00M202220232024202520260
4.95M
(OLMA) Total Revenue
(ACLX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


OLMA and ACLX have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for OLMA and ACLX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer